Based on these premises, in our vaccine strategy for Ph+ ALL, we focused our efforts in the search for p190 breakpoint peptides as strong inducers of a peptide-specific CD4+ T cell response. This evidence concerns the gene CD4 and acute lymphoblastic leukemia.